Smart CARs engineered for cancer immunotherapy
SJ Priceman, SJ Forman, CE Brown - Current opinion in oncology, 2015 - journals.lww.com
SJ Priceman, SJ Forman, CE Brown
Current opinion in oncology, 2015•journals.lww.comCAR T-cell therapeutic optimization, including intrinsic and extrinsic factors, is critical to
developing effective CAR T-cell therapies for cancer. The excitement of CAR T-cell
immunotherapy has just begun, and will continue with new insights revealed in laboratory
research and in ongoing clinical investigations.
developing effective CAR T-cell therapies for cancer. The excitement of CAR T-cell
immunotherapy has just begun, and will continue with new insights revealed in laboratory
research and in ongoing clinical investigations.
Summary
CAR T-cell therapeutic optimization, including intrinsic and extrinsic factors, is critical to developing effective CAR T-cell therapies for cancer. The excitement of CAR T-cell immunotherapy has just begun, and will continue with new insights revealed in laboratory research and in ongoing clinical investigations.
Lippincott Williams & Wilkins